Location: France, Agde
Company Profiles & Financials, D&B Company Profiles: Sastre De Rieu Yves
Complete information about Sastre De Rieu Yves
6 Jun 2012 ...
We conducted a phase 3, randomized, double-blind, placebo-controlled trial of sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients with advanced clear-cell renal-cell carcinoma. From November 2003 to March 2005, we ...
Adaptacions intantils/juvenils · Biblioteques · Borges · Calaix De Sastre
© YPPE 2017
All rights reserved
Terms of service